News Sentiment

LFMD sentiment intelligence

LifeMD Inc news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.

Chart Weekly report Factors RSS feed
Weighted score 56 Balanced news tone 50 relevant articles
Exchange NASDAQ United States
Sector Healthcare Market context
Industry Health Information Services Read-through group
Latest close 4.64 Week of 10 Jul 2026
Weighted tone 56/100

Balanced news tone

Market reaction Price moving ahead of tone

Price is moving more forcefully than the current news tone suggests.

Primary event Market update

81/100 classification confidence.

Company focus 50

directly relevant articles

Source quality 0

high-authority source matches

Trend context Trend active

-4.7% over one week, -1.3% over four weeks, trend active, and below fair value.

Latest direct headline Positive

LifeMD Rings the Nasdaq Stock Market Closing Bell

Market Reaction

Price moving ahead of tone

66/100 confidence

Price is moving more forcefully than the current news tone suggests.

Primary event Market update 81/100 classification
One-week reaction -4.7% Price reacting lower
Trend fit Trend active -1.3% over four weeks
Fair value -25.7% Below fair value
Value support

Sentiment Mix

Positive, neutral, negative

Weighted by relevance
Positive 17
Neutral 28
Negative 5

Relevance

Why the article matched

Direct first
Direct company coverage 50
Industry context 0
Sector context 0

Sources

Coverage mix

Publishers
Market source 10
Stock Titan 9
simplywall.st 7
TradingView 5
GlobeNewswire 3
TradingKey 2
Quiver Quantitative 2
Nasdaq 1

Event Lens

What the news is about

Classified themes
Market update 30
Earnings 12
Capital return 3
Deals and strategy 1
Analyst action 1
Regulatory and legal 1
Guidance 1
Balance sheet 1

Sentiment Trail

Score over time

50 baseline
Above 50 Neutral zone Below 50

News Tape

Relevant headlines

Showing 1-30 of 50
Nasdaq Direct company coverage

LifeMD Rings the Nasdaq Stock Market Closing Bell

LifeMD, a national provider of virtual healthcare and pharmacy services, celebrated by ringing the Nasdaq Stock Market Closing Bell. Co-Founders Stefan Galluppi and Justin Schreiber represented the company at the Nasdaq MarketSite in Times Square for the occasion. The event highl

Tone
Positive 72/100
Event
Market update
Published
09 Jul 2026 20:13
Source
Nasdaq
Stock Titan Direct company coverage

Federated Hermes reports 2.75M-share stake in LifeMD (LFMD)

Federated Hermes, Inc. has reported a shared beneficial ownership of 2,747,655 shares of LifeMD common stock (LFMD), representing 5.68% of the class as of June 30, 2026. The Schedule 13G filing indicates shared voting and dispositive power among Federated Hermes, the Voting Share

Tone
Neutral 50/100
Event
Deals and strategy
Published
08 Jul 2026 12:11
Source
Stock Titan
TradingView Direct company coverage

Price to book forward of LifeMD, Inc. – NASDAQ:LFMD

This page displays the "Price to book forward" financial metric for LifeMD, Inc. (NASDAQ:LFMD). The content includes general financial information for the company as found on TradingView, along with various navigation and information sections typical of such a platform.

Tone
Neutral 50/100
Event
Market update
Published
29 Jun 2026 04:10
Source
TradingView
The National Law Review Direct company coverage

LFMD SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Anno

Bronstein, Gewirtz and Grossman, LLC has announced a shareholder alert regarding LifeMD, Inc. (NASDAQ: LFMD). A class action lawsuit has been filed on behalf of investors who purchased LifeMD securities between May 7, 2025, and August 5, 2025, alleging that the company made false

Tone
Negative 24/100
Event
Regulatory and legal
Published
29 Jun 2026 02:39
Source
The National Law Review
TradingView Direct company coverage

Enterprise value to EBIT forward of LifeMD, Inc. – NASDAQ:LFMD

This article provides financial information for LifeMD, Inc. (NASDAQ: LFMD), specifically focusing on its enterprise value to EBIT forward. The content appears to be an excerpt from a financial data platform, likely TradingView, presenting a snapshot of the company's financial me

Tone
Neutral 50/100
Event
Market update
Published
27 Jun 2026 03:39
Source
TradingView
Market source Direct company coverage

LifeMD Declares Quarterly Dividend on Series A Cumulative Perpetual Preferred Stock

LifeMD, Inc. (Nasdaq: LFMD) announced that its Board of Directors authorized a cash dividend of $0.5546875 per share for holders of its 8.875% Series A Cumulative Perpetual Preferred Stock (Nasdaq: LFMDP). The dividend will be paid on July 15, 2026, to shareholders of record as o

Tone
Neutral 50/100
Event
Capital return
Published
26 Jun 2026 17:39
Source
Market source
TradingView Direct company coverage

Price to sales forward of LifeMD, Inc. – NASDAQ:LFMD

This article provides financial data for LifeMD, Inc. (NASDAQ: LFMD), specifically its price-to-sales forward ratio. The content is presented in a data-table format, indicating periods, values, and percentage changes. The information is provided by TradingView, with data sourced

Tone
Neutral 50/100
Event
Market update
Published
26 Jun 2026 03:09
Source
TradingView
TradingView Direct company coverage

Enterprise value to revenue forward of LifeMD, Inc. – NASDAQ:LFMD

This page provides financial information for LifeMD, Inc. (NASDAQ:LFMD) on TradingView, specifically focusing on its enterprise value to revenue forward metric. The content indicates that the market is currently closed with no trades. It also details the various data sources used

Tone
Neutral 50/100
Event
Earnings
Published
25 Jun 2026 19:41
Source
TradingView
Market source Direct company coverage

LifeMD Announces Exclusive Collaboration to Launch Direct-to-Patient Self-Pay Program for XYOSTED® (testosterone enanthate) Injection

LifeMD, Inc. has announced an exclusive co-marketing collaboration with Halozyme's subsidiary, Antares Pharma, Inc., to launch a direct-to-patient self-pay program for XYOSTED® (testosterone enanthate) injection. This program, launching in July 2026 across 37 states, aims to prov

Tone
Positive 74/100
Event
Market update
Published
25 Jun 2026 14:41
Source
Market source
Stock Titan Direct company coverage

LifeMD (Nasdaq: LFMD) inks exclusive telehealth collaboration for XYOSTED self-pay program

LifeMD (Nasdaq: LFMD) has announced an exclusive strategic co-marketing collaboration with Antares Pharma, a Halozyme subsidiary, to launch a direct-to-patient self-pay program for XYOSTED, an FDA-approved once-weekly subcutaneous testosterone auto-injector. This program, set to

Tone
Positive 71/100
Event
Market update
Published
22 Jun 2026 12:39
Source
Stock Titan
TradingView Direct company coverage

LifeMD to Launch Exclusive XYOSTED Self-Pay Telehealth Program in July across 37 States

LifeMD announced an exclusive telehealth co-marketing collaboration with Antares Pharma to launch a direct-to-patient self-pay XYOSTED program in July 2026. This program will initially be available in 37 states, with LifeMD's affiliated medical group evaluating patients and its p

Tone
Positive 94/100
Event
Market update
Published
22 Jun 2026 12:39
Source
TradingView
GlobeNewswire Direct company coverage

LifeMD Announces Exclusive Collaboration to Launch

LifeMD, Inc. has announced an exclusive co-marketing collaboration with Halozyme’s Antares Pharma for a direct-to-patient self-pay program for XYOSTED® (testosterone enanthate) injection. This program, launching in July 2026 in 37 states, aims to provide convenient and transparen

Tone
Positive 72/100
Event
Market update
Published
22 Jun 2026 10:40
Source
GlobeNewswire
TradingKey Direct company coverage

LifeMD Inc (LFMD) Dividends & Stock Splits: Historical Payouts and Event Timeline

This article provides an overview of LifeMD Inc's (LFMD) dividend and stock split history. It notes that the company has distributed $0.00 in dividends over the past five years and has no recorded stock split data. The page also presents current stock performance metrics and mark

Tone
Neutral 50/100
Event
Capital return
Published
18 Jun 2026 01:40
Source
TradingKey
TradingKey Direct company coverage

LifeMD Inc (LFMD) Earnings Forecast: Future EPS & Revenue Growth Estimates

This article provides an earnings forecast for LifeMD Inc (LFMD), detailing its current earnings forecast score, analyst ratings, and price targets. As of June 17, 2026, the company has an earnings forecast score of 8.25 and an average price target of $8.50 from 8 analysts, most

Tone
Positive 71/100
Event
Earnings
Published
17 Jun 2026 20:40
Source
TradingKey
MSN Direct company coverage

LifeMD, Inc. (LFMD) reports Q1 loss, tops revenue estimates

LifeMD, Inc. (LFMD) reported a narrower-than-expected loss for the first quarter, with an adjusted loss of $0.06 per share. The company also exceeded revenue estimates, generating $37.56 million compared to the anticipated $37.16 million. Despite the revenue beat, the company's n

Tone
Neutral 50/100
Event
Earnings
Published
11 Jun 2026 18:39
Source
MSN
Stock Traders Daily Direct company coverage

Understanding Momentum Shifts in (LFMDP)

This article provides an in-depth analysis of Lifemd Inc. 8.875% Series A Cumulative Perpetual Preferred Stock (NASDAQ: LFMDP), highlighting a neutral sentiment across all time horizons. It presents three distinct AI-generated trading strategies—position trading, momentum breakou

Tone
Neutral 50/100
Event
Market update
Published
10 Jun 2026 15:20
Source
Stock Traders Daily
Stock Titan Direct company coverage

LifeMD (LFMD) CTO Sripad Umesh submits initial Form 3 filing

LifeMD, Inc.'s Chief Technology Officer, Sripad Umesh, has submitted his initial Form 3 filing, an SEC document reporting beneficial ownership of securities. The filing identifies Umesh as an officer but not a ten percent owner of the company, and it states that there were no sha

Tone
Neutral 50/100
Event
Market update
Published
04 Jun 2026 01:40
Source
Stock Titan
Stock Titan Direct company coverage

LifeMD (LFMD) CTO receives 75,000-share time-vested stock grant

LifeMD, Inc.'s Chief Technology Officer, Sripad Umesh, received a grant of 75,000 shares of common stock as compensation, indicating a neutral impact and sentiment. These shares are restricted stock units that will vest in three installments over three years: 25,000 units on June

Tone
Neutral 50/100
Event
Market update
Published
04 Jun 2026 01:40
Source
Stock Titan
Moomoo Direct company coverage

Press Release: LifeMD Appoints Umesh Sripad as Chief Technology Officer

LifeMD has announced the appointment of Umesh Sripad as its new Chief Technology Officer. Sripad brings extensive experience from his previous executive roles at companies like Best Buy and Amazon, where he led significant technological advancements and strategic initiatives. His

Tone
Positive 73/100
Event
Market update
Published
02 Jun 2026 03:39
Source
Moomoo
GlobeNewswire Direct company coverage

LifeMD Appoints Umesh Sripad as Chief Technology Officer

LifeMD, Inc. has appointed Umesh Sripad as its new Chief Technology Officer, effective immediately. Mr. Sripad brings over two decades of experience in digital transformation and will be responsible for leading LifeMD's technology strategy, AI enablement, cybersecurity, and scala

Tone
Positive 73/100
Event
Market update
Published
02 Jun 2026 02:40
Source
GlobeNewswire
Stock Titan Direct company coverage

Ex-IKEA digital chief to lead AI, cybersecurity at telehealth LifeMD

LifeMD (Nasdaq: LFMD) has appointed Umesh Sripad as Chief Technology Officer to spearhead the company's technology strategy, AI initiatives, cybersecurity, and data infrastructure as it expands its direct-to-patient telehealth platform. Sripad, who previously held leadership role

Tone
Positive 62/100
Event
Market update
Published
01 Jun 2026 12:09
Source
Stock Titan